XORTX Therapeutics Statistics
Total Valuation
XRTX has a market cap or net worth of $3.72 million. The enterprise value is $1.28 million.
Important Dates
The next estimated earnings date is Friday, May 16, 2025, before market open.
Earnings Date | May 16, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
XRTX has 3.79 million shares outstanding. The number of shares has increased by 45.25% in one year.
Current Share Class | 3.79M |
Shares Outstanding | 3.79M |
Shares Change (YoY) | +45.25% |
Shares Change (QoQ) | +12.82% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.11 |
P/TBV Ratio | 1.18 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.53, with a Debt / Equity ratio of 0.01.
Current Ratio | 3.53 |
Quick Ratio | 3.29 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -83.06% and return on invested capital (ROIC) is -40.74%.
Return on Equity (ROE) | -83.06% |
Return on Assets (ROA) | -34.21% |
Return on Invested Capital (ROIC) | -40.74% |
Return on Capital Employed (ROCE) | -78.43% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.10M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.46% in the last 52 weeks. The beta is -0.21, so XRTX's price volatility has been lower than the market average.
Beta (5Y) | -0.21 |
52-Week Price Change | -75.46% |
50-Day Moving Average | 0.94 |
200-Day Moving Average | 1.40 |
Relative Strength Index (RSI) | 43.55 |
Average Volume (20 Days) | 16,846 |
Short Selling Information
The latest short interest is 24,840, so 0.66% of the outstanding shares have been sold short.
Short Interest | 24,840 |
Short Previous Month | 70,090 |
Short % of Shares Out | 0.66% |
Short % of Float | 0.75% |
Short Ratio (days to cover) | 0.02 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.62M |
Pretax Income | -3.34M |
Net Income | -3.31M |
EBITDA | -2.58M |
EBIT | -2.62M |
Earnings Per Share (EPS) | -$1.15 |
Full Income Statement Balance Sheet
The company has $2.47 million in cash and $38,785 in debt, giving a net cash position of $2.43 million or $0.64 per share.
Cash & Cash Equivalents | 2.47M |
Total Debt | 38,785 |
Net Cash | 2.43M |
Net Cash Per Share | $0.64 |
Equity (Book Value) | 3.34M |
Book Value Per Share | 0.96 |
Working Capital | 1.92M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -3.68M |
Capital Expenditures | n/a |
Free Cash Flow | -3.68M |
FCF Per Share | -$0.97 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |